Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells

Thomas W. Grunt(Comprehensive Cancer Center Vienna), Christian Dittrich(Leibniz Institute for Agricultural Engineering and Bioeconomy), Georg Krupitza(Medical University of Vienna), Ruth Lupu(Mayo Clinic in Arizona), H. Huber(Munich University of Applied Sciences), Mary Beth Martin(Georgetown University), Hanna Harant(University of Vienna), E. Dittrich(University of Vienna), Miguel Saceda(Universitat de Miguel Hernández d'Elx)
International Journal of Cancer
November 15, 1995
Cited by 70


Related Papers